Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ironwood Pharmaceuticals Inc IRWD

Healthcare Biotechnology
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of... see more

Recent & Breaking News (NDAQ:IRWD)

Ironwood Pharmaceuticals to Present at Wells Fargo 2016 Healthcare Conference

Business Wire September 1, 2016

Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma

PR Newswire August 24, 2016

Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update

Business Wire August 4, 2016

Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call

Business Wire July 21, 2016

Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma

PR Newswire June 10, 2016

Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review

PR Newswire June 9, 2016

Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference

Business Wire June 6, 2016

Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad

Business Wire June 3, 2016

Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference

Business Wire June 1, 2016

Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference

Business Wire May 18, 2016

Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016

Business Wire May 17, 2016

Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update

Business Wire May 9, 2016

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference

Business Wire May 3, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ironwood Pharmaceuticals, Inc. (IRWD)

PR Newswire April 28, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ironwood Pharmaceuticals, Inc. - IRWD

PR Newswire April 28, 2016

IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Ironwood Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire April 27, 2016

INVESTOR ALERT: Investigation of Ironwood Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith

Business Wire April 27, 2016

Ironwood Pharmaceuticals Investigated for Potential Violations of Federal Securities Laws by Block & Leviton LLP

PR Newswire April 26, 2016

Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call

Business Wire April 25, 2016

Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors

Business Wire April 7, 2016